Associated Papers
EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.
Li Z et al.
Bmc Pulmonary Medicine, 2022
36123678 (PubMed )
Supplement: 12890_2022_2161_MOESM2_ESM.xlsx › OAK_POPLAR_btmb_variants
Multiplexed Functional Assessment of Genetic Variants in CARD11.
Meitlis I et al.
American Journal of Human Genetics, 2020
33202260 (PubMed )
Supplement: mmc7.xlsx › dmso___LOF_screen__
Select a paper to view details